Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea · Delayed Price · Currency is KRW 10,090
+1,250 (14.14%)
At close: Aug 28, 2026
KRX:019170 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 521,417 | 738,559 | 539,247 | 707,263 | 1,124,818 | 1,653,859 | |
Market Cap Growth | -21.72% | 36.96% | -23.76% | -37.12% | -31.99% | -73.97% |
Enterprise Value | 503,244 | 728,856 | 521,260 | 679,012 | 1,050,665 | 1,521,791 |
Last Close Price | 10090.00 | 14040.00 | 10310.00 | 13520.00 | 21150.00 | 31950.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 87.37 | - | - | - | - |
PS Ratio | 2.18 | 3.15 | 2.44 | 3.53 | 5.38 | 8.74 |
PB Ratio | 1.88 | 2.73 | 2.09 | 2.61 | 3.40 | 4.59 |
P/TBV Ratio | 1.92 | 2.79 | 2.14 | 2.68 | 3.49 | 4.72 |
P/FCF Ratio | 38.41 | 53.61 | - | - | - | - |
P/OCF Ratio | 29.68 | 42.81 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.11 | 3.11 | 2.36 | 3.39 | 5.02 | 8.04 |
EV/EBITDA Ratio | 35.93 | 28.42 | - | - | - | - |
EV/EBIT Ratio | 186.97 | 51.13 | - | - | - | - |
EV/FCF Ratio | 37.07 | 52.91 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.19 | 0.21 | 0.21 | 0.17 | 0.01 | 0.00 |
Debt / EBITDA Ratio | 3.80 | 2.18 | - | - | - | - |
Debt / FCF Ratio | 3.93 | 4.05 | - | - | - | - |
Net Debt / Equity Ratio | -0.07 | -0.06 | -0.01 | -0.05 | -0.16 | -0.25 |
Net Debt / EBITDA Ratio | -1.36 | -0.61 | 0.37 | 0.41 | 2.55 | 56.11 |
Net Debt / FCF Ratio | -1.40 | -1.14 | 0.09 | 0.36 | 1.70 | 1.21 |
Asset Turnover | 0.68 | 0.68 | 0.64 | 0.56 | 0.55 | 0.43 |
Inventory Turnover | 2.25 | 2.32 | 2.55 | 2.38 | 2.78 | 2.31 |
Quick Ratio | 1.97 | 2.17 | 1.70 | 1.86 | 5.39 | 6.39 |
Current Ratio | 2.86 | 3.09 | 2.50 | 2.60 | 7.24 | 8.16 |
Return on Equity (ROE) | -0.28% | 3.17% | -5.81% | -19.04% | -10.22% | -3.11% |
Return on Assets (ROA) | 0.48% | 2.57% | -3.08% | -8.33% | -5.60% | -2.01% |
Return on Invested Capital (ROIC) | -134.33% | 5.54% | -6.64% | -17.78% | -12.47% | -6.22% |
Return on Capital Employed (ROCE) | 0.90% | 5.00% | -6.40% | -17.30% | -10.20% | -3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.23% | 1.20% | -2.85% | -8.11% | -3.15% | -0.70% |
FCF Yield | 2.60% | 1.86% | -3.84% | -5.61% | -2.82% | -4.56% |
Buyback Yield / Dilution | -23.67% | 3.62% | 0.28% | - | - | -1.85% |
Total Shareholder Return | -23.67% | 3.62% | 0.28% | - | - | -1.85% |